Cytomegalovirus (CMV) shedding is highly correlated with markers of immunosuppression in CMV-seropositive women Free

Abstract

Cytomegalovirus (CMV) enters latency following primary infection and can subsequently reactivate. Reinfection with a different viral strain can also occur. During these events, CMV is shed in bodily fluids. This study examined correlates of CMV shedding in specimens obtained from the HIV Epidemiology Research Study, a multicenter cohort study of US women with or at high risk for human immunodeficiency virus (HIV) infection. Among the women studied, 91.4 % (911/997) were CMV IgG seropositive. Of these women, 2.7 % (25/911) were CMV IgM seropositive. CMV DNA was detected via real-time PCR more frequently in cervicovaginal lavage (CVL) specimens (55/764, 7.2 %) than in peripheral blood mononuclear cells (PBMCs) (26/897, 2.9 %). CMV viral loads in 1 ml CVL (median 534; mean 2598; range = 40–74 844) were higher than in 10 PBMCs (median 264; mean 1287; range = 35–13 250). CMV DNA in PBMCs was associated with HIV seropositivity [odds ratio (OR) 13.5; 95 % confidence interval (CI) 1.8–100], increasing HIV viral load (<0.001 for trend), decreasing CD4 cell counts (<0.001 for trend) and CMV DNA in CVL (OR 26; 95 % CI 10.7–64). CMV DNA in CVL specimens was associated with CMV IgM seropositivity (OR 4.3; 95 % CI 1.5–12.3), HIV seropositivity (OR 7.3; 95 % CI 2.6–20), increasing HIV viral load (<0.001 for trend) and decreasing CD4 cell counts (<0.001 for trend). The positive predictive value of CMV IgM seropositivity for CMV DNA shedding in either PBMCs or CVL was 20 %. In summary, CMV shedding in CVL and PBMCs was highly correlated with each other and with markers of immune suppression.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.027771-0
2011-06-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jmm/60/6/768.html?itemId=/content/journal/jmm/10.1099/jmm.0.027771-0&mimeType=html&fmt=ahah

References

  1. Bello C., Whittle H. 1991; Cytomegalovirus infection in Gambian mothers and their babies. J Clin Pathol 44:366–369 [View Article][PubMed]
    [Google Scholar]
  2. Biri A., Bozdayi G., Ciçfti B., Dinç B., Yücel A., Rota S. 2006; The detection of CMV in amniotic fluid and cervicovaginal smear samples by real-time PCR assay in prenatal diagnosis. Arch Gynecol Obstet 273:261–266 [View Article][PubMed]
    [Google Scholar]
  3. Boppana S. B., Fowler K. B., Pass R. F., Rivera L. B., Bradford R. D., Lakeman F. D., Britt W. J. 2005; Congenital cytomegalovirus infection: association between virus burden in infancy and hearing loss. J Pediatr 146:817–823 [View Article][PubMed]
    [Google Scholar]
  4. Broccolo F., Cassina G., Chiari S., Garcia-Parra R., Villa A., Leone B. E., Brenna A., Locatelli G., Mangioni C., Cocuzza C. E. 2008; Frequency and clinical significance of human β-herpesviruses in cervical samples from Italian women. J Med Virol 80:147–153 [View Article][PubMed]
    [Google Scholar]
  5. Cannon M. J., Davis K. F. 2005; Washing our hands of the congenital cytomegalovirus disease epidemic. BMC Public Health 5:70 [View Article][PubMed]
    [Google Scholar]
  6. Cannon M. J., Dollard S. C., Smith D. K., Klein R. S., Schuman P., Rich J. D., Vlahov D., Pellett P. E. for the HIV Epidemiology Research Study Group 2001; Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection. N Engl J Med 344:637–643 [View Article][PubMed]
    [Google Scholar]
  7. Chandler S. H., Holmes K. K., Wentworth B. B., Gutman L. T., Wiesner P. J., Alexander E. R., Handsfield H. H. 1985; The epidemiology of cytomegaloviral infection in women attending a sexually transmitted disease clinic. J Infect Dis 152:597–605[PubMed] [CrossRef]
    [Google Scholar]
  8. Chandler S. H., Handsfield H. H., McDougall J. K. 1987; Isolation of multiple strains of cytomegalovirus from women attending a clinic for sexually transmitted disease. J Infect Dis 155:655–660[PubMed] [CrossRef]
    [Google Scholar]
  9. Clarke L. M., Duerr A., Feldman J., Sierra M. F., Daidone B. J., Landesman S. H. 1996; Factors associated with cytomegalovirus infection among human immunodeficiency virus type 1-seronegative and -seropositive women from an urban minority community. J Infect Dis 173:77–82[PubMed] [CrossRef]
    [Google Scholar]
  10. Collier A. C., Handsfield H. H., Ashley R., Roberts P. L., DeRouen T., Meyers J. D., Corey L. 1995; Cervical but not urinary excretion of cytomegalovirus is related to sexual activity and contraceptive practices in sexually active women. J Infect Dis 171:33–38[PubMed] [CrossRef]
    [Google Scholar]
  11. Coonrod D., Collier A. C., Ashley R., DeRouen T., Corey L. 1998; Association between cytomegalovirus seroconversion and upper genital tract infection among women attending a sexually transmitted disease clinic: a prospective study. J Infect Dis 177:1188–1193 [View Article][PubMed]
    [Google Scholar]
  12. Cope A. V., Sweny P., Sabin C., Rees L., Griffiths P. D., Emery V. C. 1997; Quantity of cytomegalovirus viruria is a major risk factor for cytomegalovirus disease after renal transplantation. J Med Virol 52:200–205 [View Article][PubMed]
    [Google Scholar]
  13. de Jong M. D., Boucher C. A. B., Danner S. A., Gazzard B., Griffiths P. D., Katlama C., Lange J. M. A., Richman D. D., Vella S. 1998; Summary of the international consensus symposium on management of HIV, CMV and hepatitis virus infections. Antiviral Res 37:1–16 [View Article][PubMed]
    [Google Scholar]
  14. Delany S., Rosas R., Mlaba N., Clayton T., Akpomiemie G., LeGoff J., Capovilla A., Bélec L., Stevens W., Mayaud P. 2008; Comparison of cervicovaginal lavage, cervicovaginal lavage enriched with cervical swab, and vaginal tampon for the detection of HIV-1 RNA and HSV-2 DNA in genital secretions. J Acquir Immune Defic Syndr 49:406–409 [View Article][PubMed]
    [Google Scholar]
  15. Demmler G. J., Yow M. D., Spector S. A., Reis S. G., Brady M. T., Anderson D. C., Taber L. H. 1987; Nosocomial cytomegalovirus infections within two hospitals caring for infants and children. J Infect Dis 156:9–16[PubMed] [CrossRef]
    [Google Scholar]
  16. Dollard S. C., Grosse S. D., Ross D. S. 2007; New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 17:355–363 [View Article][PubMed]
    [Google Scholar]
  17. Emery V. C., Sabin C., Feinberg J. E., Grywacz M., Knight S., Griffiths P. D. for the AIDS Clinical Trials Group 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study Group 1999; Quantitative effects of valacyclovir on the replication of cytomegalovirus (CMV) in persons with advanced human immunodeficiency virus disease: baseline CMV load dictates time to disease and survival. J Infect Dis 180:695–701 [View Article][PubMed]
    [Google Scholar]
  18. Fowler K. B., Pass R. F. 1991; Sexually transmitted diseases in mothers of neonates with congenital cytomegalovirus infection. J Infect Dis 164:259–264[PubMed] [CrossRef]
    [Google Scholar]
  19. Griffiths P. D., Stagno S., Reynolds D. W., Alford C. A. 1978; A longitudinal study of the serological and virological status of 18 women infected with cytomegalovirus. Arch Virol 58:111–118 [View Article][PubMed]
    [Google Scholar]
  20. Grosse S. D., Ross D. S., Dollard S. C. 2008; Congenital cytomegalovirus (CMV) infection as a cause of permanent bilateral hearing loss: a quantitative assessment. J Clin Virol 41:57–62 [View Article][PubMed]
    [Google Scholar]
  21. Kangro H. O., Griffiths P. D., Huber T. J., Heath R. B. 1982; Specific IgM class antibody production following infection with cytomegalovirus. J Med Virol 10:203–212 [View Article][PubMed]
    [Google Scholar]
  22. Kaye S., Miles D., Antoine P., Burny W., Ojuola B., Kaye P., Rowland-Jones S., Whittle H., van der Sande M., Marchant A. 2008; Virological and immunological correlates of mother-to-child transmission of cytomegalovirus in The Gambia. J Infect Dis 197:1307–1314 [View Article][PubMed]
    [Google Scholar]
  23. Kenneson A., Cannon M. J. 2007; Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 17:253–276 [View Article][PubMed]
    [Google Scholar]
  24. Kharrazi M., Hyde T., Young S., Amin M. M., Cannon M. J., Dollard S. C. 2010; Use of screening dried blood spots for estimation of prevalence, risk factors, and birth outcomes of congenital cytomegalovirus infection. J Pediatr 157:191–197 [View Article][PubMed]
    [Google Scholar]
  25. Lazzarotto T., Dalla Casa B., Campisi B., Landini M. P. 1992; Enzyme-linked immunoadsorbent assay for the detection of cytomegalovirus-IgM: comparison between eight commercial kits, immunofluorescence, and immunoblotting. J Clin Lab Anal 6:216–218 [View Article][PubMed]
    [Google Scholar]
  26. Mocarski E. S. Jr, Shenk T., Pass R. F. 2007; Cytomegaloviruses. In Fields Virology, 5th edn. pp. 2702–2772 Edited by Knipe D. M., Howley P. M. Philadelphia: Lippincott Williams & Wilkins;
    [Google Scholar]
  27. Nankervis G. A., Kumar M. L., Cox F. E., Gold E. 1984; A prospective study of maternal cytomegalovirus infection and its effect on the fetus. Am J Obstet Gynecol 149:435–440[PubMed] [CrossRef]
    [Google Scholar]
  28. Natali A., Valcavi P., Medici M. C., Dieci E., Montali S., Chezzi C. 1997; Cytomegalovirus infection in an Italian population: antibody prevalence, virus excretion and maternal transmission. New Microbiol 20:123–133[PubMed]
    [Google Scholar]
  29. Novak Z., Ross S. A., Patro R. K., Pati S. K., Kumbla R. A., Brice S., Boppana S. B. 2008; Cytomegalovirus strain diversity in seropositive women. J Clin Microbiol 46:882–886 [View Article][PubMed]
    [Google Scholar]
  30. Numazaki Y., Yano N., Morizuka T., Takai S., Ishida N. 1970; Primary infection with human cytomegalovirus: virus isolation from healthy infants and pregnant women. Am J Epidemiol 91:410–417[PubMed]
    [Google Scholar]
  31. Pass R. F., Stagno S., Dworsky M. E., Smith R. J., Alford C. A. 1982; Excretion of cytomegalovirus in mothers: observations after delivery of congenitally infected and normal infants. J Infect Dis 146:1–6[PubMed] [CrossRef]
    [Google Scholar]
  32. Pereira L. H., Embil J. A., Haase D. A., Manley K. M. 1990; Cytomegalovirus infection among women attending a sexually transmitted disease clinic: association with clinical symptoms and other sexually transmitted diseases. Am J Epidemiol 131:683–692[PubMed]
    [Google Scholar]
  33. Pereira L., Maidji E., McDonagh S., Tabata T. 2005; Insights into viral transmission at the uterine–placental interface. Trends Microbiol 13:164–174 [View Article][PubMed]
    [Google Scholar]
  34. Read J. S., Cannon M. J., Stanberry L. R., Schuval S. 2008; Prevention of mother-to-child transmission of viral infections. Curr Probl Pediatr Adolesc Health Care 38:274–297 [View Article][PubMed]
    [Google Scholar]
  35. Revello M. G., Zavattoni M., Sarasini A., Percivalle E., Simoncini L., Gerna G. 1998; Human cytomegalovirus in blood of immunocompetent persons during primary infection: prognostic implications for pregnancy. J Infect Dis 177:1170–1175 [View Article][PubMed]
    [Google Scholar]
  36. Rosenthal L. S., Fowler K. B., Boppana S. B., Britt W. J., Pass R. F., Schmid S. D., Stagno S., Cannon M. J. 2009; Cytomegalovirus shedding and delayed sensorineural hearing loss: results from longitudinal follow-up of children with congenital infection. Pediatr Infect Dis J 28:515–520 [View Article][PubMed]
    [Google Scholar]
  37. Ross S. A., Novak Z., Ashrith G., Rivera L. B., Britt W. J., Hedges S., Schwebke J. R., Boppana A. S. 2005; Association between genital tract cytomegalovirus infection and bacterial vaginosis. J Infect Dis 192:1727–1730 [View Article][PubMed]
    [Google Scholar]
  38. Shen C.-Y., Chang S.-F., Chao M.-F., Huang E.-S., Wu C.-W. 1993a; Identification of a serial change in recurrent cytomegalovirus strains in a healthy child by polymerase chain reaction. J Infect Dis 168:252–253[PubMed] [CrossRef]
    [Google Scholar]
  39. Shen C.-Y., Chang S.-F., Yen M.-S., Ng H.-T., Huang E.-S., Wu C.-W. 1993b; Cytomegalovirus excretion in pregnant and nonpregnant women. J Clin Microbiol 31:1635–1636[PubMed]
    [Google Scholar]
  40. Shen C.-Y., Chang S.-F., Chao M.-F., Yang S.-L., Lin G.-M., Chang W.-W., Wu C.-W., Yen M.-S., Ng H.-T. et al. 1993c; Cytomegalovirus recurrence in seropositive pregnant women attending obstetric clinics. J Med Virol 41:24–29 [View Article][PubMed]
    [Google Scholar]
  41. Shen C.-Y., Chang S.-F., Lin H.-J., Ho H.-N., Yeh T.-S., Yang S.-L., Huang E.-S., Wu C.-W. 1994; Cervical cytomegalovirus infection in prostitutes and in women attending a sexually transmitted disease clinic. J Med Virol 43:362–366 [View Article][PubMed]
    [Google Scholar]
  42. Smith D. K., Warren D. L., Vlahov D., Schuman P., Stein M. D., Greenberg B. L., Holmberg S. D. 1997; Design and baseline participant characteristics of the Human Immunodeficiency Virus Epidemiology Research (HER) Study: a prospective cohort study of human immunodeficiency virus infection in US women. Am J Epidemiol 146:459–469[PubMed] [CrossRef]
    [Google Scholar]
  43. Spano L. C., Gatti J., Nascimento J. P., Leite J. P. 2004; Prevalence of human cytomegalovirus infection in pregnant and non-pregnant women. J Infect 48:213–220 [View Article][PubMed]
    [Google Scholar]
  44. Stagno S., Reynolds D., Tsiantos A., Fuccillo D. A., Smith R., Tiller M., Alford C. A. Jr 1975; Cervical cytomegalovirus excretion in pregnant and nonpregnant women: suppression in early gestation. J Infect Dis 131:522–527[PubMed] [CrossRef]
    [Google Scholar]
  45. Stover C. T., Smith D. K., Schmid D. S., Pellett P. E., Stewart J. A., Klein R. S., Mayer K., Vlahov D., Schuman P. et al. 2003; Prevalence of and risk factors for viral infections among human immunodeficiency virus (HIV)-infected and high-risk HIV-uninfected women. J Infect Dis 187:1388–1396 [View Article][PubMed]
    [Google Scholar]
  46. Stratton K. R., Durch J. S., Lawrence R. S. editors 2000 Vaccines for the 21st Century: A Tool for Decision Making Washington, DC: National Academy Press;
    [Google Scholar]
  47. Szekeres-Bartho J. 2002; Immunological relationship between the mother and the fetus. Int Rev Immunol 21:471–495 [View Article][PubMed]
    [Google Scholar]
  48. Tanaka K., Yamada H., Minami M., Kataoka S., Numazaki K., Minakami H., Tsutsumi H. 2006; Screening for vaginal shedding of cytomegalovirus in healthy pregnant women using real-time PCR: correlation of CMV in the vagina and adverse outcome of pregnancy. J Med Virol 78:757–759 [View Article][PubMed]
    [Google Scholar]
  49. Zanghellini F., Boppana S. B., Emery V. C., Griffiths P. D., Pass R. F. 1999; Asymptomatic primary cytomegalovirus infection: virologic and immunologic features. J Infect Dis 180:702–707 [View Article][PubMed]
    [Google Scholar]
  50. Zhang C., Buchanan H., Andrews W., Evans A., Pass R. F. 2006; Detection of cytomegalovirus infection during a vaccine clinical trial in healthy young women: seroconversion and viral shedding. J Clin Virol 35:338–342 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.027771-0
Loading
/content/journal/jmm/10.1099/jmm.0.027771-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed